Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
9.19
-0.19 (-2.03%)
At close: Aug 21, 2026, 4:00 PM EDT
9.19
0.00 (0.00%)
After-hours: Aug 21, 2026, 4:10 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $98.92 million as of August 21, 2026. Its market cap has increased by 68.56% in one year.
Market Cap
98.92M
Enterprise Value
-6.41M
1-Year Change
68.56%
Ranking
Category
Stock Price
$9.19
ChartMarket Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $98.92M, a decrease of -67.21%. That is a compound annual growth rate of -17.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 98.92M | 16.25% |
| Dec 31, 2025 | 85.10M | -2.63% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fractyl Health | 109.05M |
| Yarrow Bioscience | 106.96M |
| Polaryx Therapeutics | 106.67M |
| Cue Biopharma | 103.37M |
| PolyPid | 103.18M |
| Oncolytics Biotech | 102.23M |
| Tenax Therapeutics | 101.96M |
| Biomea Fusion | 98.58M |